ESR1 mutation
-
Health
FDA grants accelerated approval to Etcamah for ESR1-mutated advanced breast cancer
The ctDNA-guided approval allows an early treatment switch before imaging shows progression, while confirmatory evidence and important safety warnings remain.
Read More »
